Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Generation Bio Co. - Common stock (NQ:GBIO)

0.3600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Generation Bio Co. - Common stock

< Previous 1 2 3 4 Next >
Curious about the stocks that are showing activity after the closing bell on Friday?
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Where Generation Bio Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
From Generation Bio Co.
Via GlobeNewswire
Which stocks are moving after the closing bell on Friday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Generation Bio Reports Second Quarter 2024 Financial Results
Cash balance of $217 million still expected to fund operations into 2H 2027 
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023
GBIO stock results show that Generation Bio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
From Generation Bio Co.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.